Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology GroupPasquale Comella, Giuseppe Comella, G. Frasci et al.|Journal of Clinical Oncology|2000Cited by 177
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancerGiampietro Gasparini, Dino Amadori, Massimo Gion et al.|Breast Cancer Research and Treatment|2006Cited by 140
Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experienceE.S. Lutrino, Saverio Cinieri, Laura Orlando et al.|Tumori Journal|2019Cited by 6
Biweekly Combination of Trastuzumab, Docetaxel and Gemcitabine for HER2-Positive Metastatic Breast Cancer: Results of a Phase II GOIM StudyLaura Orlando, Francesco Giotta, Ferdinando De Vita et al.|Future Oncology|2014Cited by 3
Impact of Anemia Management with EPO on Psychologic Distress in Cancer Patients: Results of a Multicenter Patient SurveySalvatore Del Prete, Raffaele Addeo, Saverio Cinieri et al.|Future Oncology|2013Cited by 2